Altre lingue NextCell Pharma AB

Azioni

NXTCL

SE0009723125

Mercato chiuso - Nasdaq Stockholm Altri mercati azionari 15:38:50 17/05/2024			Variaz. 5gg	Var. 1 gen.
1,28 ^SEK	-0,78%		+1,99%	-51,33%

25/04	NextCell Pharma AB riporta i risultati degli utili per il secondo trimestre e i sei mesi conclusi il 29 febbraio 2024	CI
22/04	NextCell Pharma AB annuncia che l'Ispettorato svedese per l'assistenza sanitaria e sociale concede al suo stabilimento di tessuti Cellaviva l'autorizzazione a trattare il tessuto amniotico	CI

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

NextCell publishes its Interim Report 2 2023/2024	25/04
NextCell Pharma AB Reports Earnings Results for the Second Quarter and Six Months Ended February 29, 2024	25/04
Notice of Extraordinary General Meeting in NextCell Pharma AB (publ)	24/04
The Board of Directors of NextCell resolves on a rights issue of units of approximately SEK 40.1 million, subject to approval by an Extraordinary General Meeting	24/04
NextCell's daughter company Cellaviva granted permission to handle amniotic tissue	22/04
NextCell Pharma AB Announces Swedish Health and Social Care Inspectorate Grants Their Cellaviva Tissue Establishment Permission to Handle Amniotic Tissue	22/04
NextCell Pharma Chairman to Step Down in May	19/04
Anders Essen-Möller resigns as Chairman of the Board of Directors due to health reasons	19/04
Anders Essen-Möller Resigns as Chairman of NextCell Pharma AB	19/04
The Swedish Medical Products Agency approves subgroup analysis in NextCell's ProTrans-Young study	27/03
The Swedish Medical Products Agency Approves Subgroup Analysis in NextCell Pharma AB's ProTrans-Young study	27/03
NextCell establishes QVance to meet the Nordic's need for quality analytics	14/03
NextCell Pharma AB Establishes QVance to Meet the Nordic's Need for Quality Analytics	14/03
NextCell Pharma's updated growth strategy	27/02
NextCell Pharma presents at Redeye Theme: Regenerative Medicine/Cell Therapy	14/02
NextCell Pharma AB Reports Earnings Results for the First Quarter Ended November 30, 2023	25/01
NextCell publishes its Interim Report 1 2023/2024	25/01
Updates regarding NextCell's Clinical Trials with ProTrans	24/01
Nextcell Pharma Announces Updates Regarding Nextcell's Clinical Trials with Protrans	24/01
NextCell Pharma has compiled a Q&A section	13/12

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue NextCell Pharma AB

Azioni

NXTCL

SE0009723125

Altre lingue

Filtri